Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on copper catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114014865A details a Cu-catalyzed oxidative coupling for asymmetric trimeric indoles, offering high yields and simplified purification for electronic chemical manufacturing.
Patent CN109608401A reveals chitosan-copper catalysis for diarylamines. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing processes.
Patent CN112110951A reveals a novel aqueous-phase radical coupling method for Bryostatin C-ring precursors, offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Patent CN112341417A details a novel light/copper co-catalyzed route for polysubstituted furans, offering mild conditions and enhanced supply chain reliability for pharmaceutical intermediates.
Patent CN112441875B reveals a green copper photocatalytic route for 9-trifluoromethyl-9,10-dihydrophenanthrene, offering mild conditions and high atom economy for pharmaceutical intermediates.
Novel copper catalyzed method for cyclic carbonate synthesis using CO2. Offers safe scalable production for pharmaceutical intermediates with reduced environmental impact.
Patent CN119775259B details a novel resin-supported catalyst method for high-purity Amatinib intermediate production, offering significant supply chain and cost advantages.
Novel copper-palladium catalyzed route for 3-aryl pyrroles. Enhances purity and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN110903189B details a cost-effective copper-catalyzed route for chiral 2-aryl propionates, offering significant supply chain advantages for NSAID intermediate manufacturing.
Novel photo-copper catalysis method enables efficient delta-lactone synthesis with high enantioselectivity. This technology offers reliable supply chain solutions and cost reduction in pharmaceutical intermediate manufacturing for global partners.
Novel Cu(phen)2BF4 catalyst enables efficient diphenyl ether synthesis. Reduces costs and improves supply chain reliability for pharma and fragrance intermediates.
Patent CN105732377B reveals high-yield indanone synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel copper-catalyzed asymmetric propargyl substitution method ensures high ee and scalable production for pharmaceutical intermediates.
Novel copper-catalyzed decarboxylative acylation method offers mild conditions and high yields for reliable pharmaceutical intermediate supply chains.
Patent CN110590819A introduces a chitosan-copper catalyzed method for organoboron compounds. Offers cost reduction in pharmaceutical intermediates manufacturing with water-based green chemistry.
Patent CN113444076A details a green three-component synthesis for fluorinated quinoxalinones, offering recyclable catalysis and reduced metal residues for pharmaceutical manufacturing.
Patent CN113444076A reveals a recyclable chitosan-copper catalyst for synthesizing fluorinated quinoxalinones, offering sustainable cost reduction and high purity for pharma manufacturing.
Patent CN103819414B enables green aqueous synthesis of quinazolinones. Reduces solvent costs and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN117586151A details a stable three-step synthesis for Fmoc-Asp(OtBu)-OH ensuring high purity and efficient supply chain reliability for global peptide manufacturers.
Patent CN113582865A details a novel copper-catalyzed route for alpha,alpha-disubstituted chiral amino acid esters, offering high enantioselectivity and streamlined manufacturing for API intermediates.